Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cyrine Ezzili

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Bioorganic & Medicinal Chemistry Letters|September 7, 2010
Fatty acid amide signaling moleculesCyrine Ezzili, Katerina Otrubova, Dale L Boger
Bioorganic & Medicinal Chemistry Letters|July 19, 2011
The discovery and development of inhibitors of fatty acid amide hydrolase (FAAH)Katerina Otrubova, Cyrine Ezzili, Dale L Boger
BMJ Open|February 17, 2025
Opioid-free versus opioid-based anaesthesia for free-flap reconstruction surgery of the breast: protocol for a phase III, multicentre, randomised controlled studyMary Saad-Boutry, Matthieu Carton, Cyrine Ezzili, et al.
Journal of the American Chemical Society|March 2, 2011
Fluoride-mediated capture of a noncovalent bound state of a reversible covalent enzyme inhibitor: X-ray crystallographic analysis of an exceptionally potent α-ketoheterocycle inhibitor of fatty acid amide hydrolaseMauro Mileni, Joie Garfunkle, Cyrine Ezzili, et al.
Journal of Medicinal Chemistry|July 18, 2008
Optimization of the central heterocycle of alpha-ketoheterocycle inhibitors of fatty acid amide hydrolaseJoie Garfunkle, Cyrine Ezzili, Thomas J Rayl, et al.
Journal of Medicinal Chemistry|November 21, 2009
X-ray crystallographic analysis of alpha-ketoheterocycle inhibitors bound to a humanized variant of fatty acid amide hydrolaseMauro Mileni, Joie Garfunkle, Cyrine Ezzili, et al.
International Journal of Radiation Oncology, Biology, Physics|September 24, 2020
Combination of Olaparib and Radiation Therapy for Triple Negative Breast Cancer: Preliminary Results of the RADIOPARP Phase 1 TrialPierre Loap, Delphine Loirat, Frederique Berger, et al.
Journal of Medicinal Chemistry|February 6, 2008
Optimization of alpha-ketooxazole inhibitors of fatty acid amide hydrolaseF Scott Kimball, F Anthony Romero, Cyrine Ezzili, et al.
Cancer Chemotherapy and Pharmacology|September 14, 2014
Clinical study of the novel cyclin-dependent kinase inhibitor dinaciclib in combination with rituximab in relapsed/refractory chronic lymphocytic leukemia patientsClaire Fabre, Marco Gobbi, Cyrine Ezzili, et al.
British Journal of Pharmacology|April 22, 2011
The fatty acid amide hydrolase (FAAH) inhibitor PF-3845 acts in the nervous system to reverse LPS-induced tactile allodynia in miceLamont Booker, Steven G Kinsey, Rehab A Abdullah, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Bioorganic & Medicinal Chemistry Letters|September 7, 2010
Fatty acid amide signaling moleculesCyrine Ezzili, Katerina Otrubova, Dale L Boger
Bioorganic & Medicinal Chemistry Letters|July 19, 2011
The discovery and development of inhibitors of fatty acid amide hydrolase (FAAH)Katerina Otrubova, Cyrine Ezzili, Dale L Boger
BMJ Open|February 17, 2025
Opioid-free versus opioid-based anaesthesia for free-flap reconstruction surgery of the breast: protocol for a phase III, multicentre, randomised controlled studyMary Saad-Boutry, Matthieu Carton, Cyrine Ezzili, et al.
Journal of the American Chemical Society|March 2, 2011
Fluoride-mediated capture of a noncovalent bound state of a reversible covalent enzyme inhibitor: X-ray crystallographic analysis of an exceptionally potent α-ketoheterocycle inhibitor of fatty acid amide hydrolaseMauro Mileni, Joie Garfunkle, Cyrine Ezzili, et al.
Journal of Medicinal Chemistry|July 18, 2008
Optimization of the central heterocycle of alpha-ketoheterocycle inhibitors of fatty acid amide hydrolaseJoie Garfunkle, Cyrine Ezzili, Thomas J Rayl, et al.
Journal of Medicinal Chemistry|November 21, 2009
X-ray crystallographic analysis of alpha-ketoheterocycle inhibitors bound to a humanized variant of fatty acid amide hydrolaseMauro Mileni, Joie Garfunkle, Cyrine Ezzili, et al.
International Journal of Radiation Oncology, Biology, Physics|September 24, 2020
Combination of Olaparib and Radiation Therapy for Triple Negative Breast Cancer: Preliminary Results of the RADIOPARP Phase 1 TrialPierre Loap, Delphine Loirat, Frederique Berger, et al.
Journal of Medicinal Chemistry|February 6, 2008
Optimization of alpha-ketooxazole inhibitors of fatty acid amide hydrolaseF Scott Kimball, F Anthony Romero, Cyrine Ezzili, et al.
Cancer Chemotherapy and Pharmacology|September 14, 2014
Clinical study of the novel cyclin-dependent kinase inhibitor dinaciclib in combination with rituximab in relapsed/refractory chronic lymphocytic leukemia patientsClaire Fabre, Marco Gobbi, Cyrine Ezzili, et al.
British Journal of Pharmacology|April 22, 2011
The fatty acid amide hydrolase (FAAH) inhibitor PF-3845 acts in the nervous system to reverse LPS-induced tactile allodynia in miceLamont Booker, Steven G Kinsey, Rehab A Abdullah, et al.
Pageof 2